Compugen Ltd. (NASDAQ: CGEN) 63% HIGHER; announced today that it has signed a collaboration agreement with Pfizer for the predictive discovery by Compugen of therapeutic peptide product candidates for three drug targets of interest to Pfizer.
The discovery process, which will be based on various Compugen discovery platforms and funded by Pfizer, is expected to take a few months, following which the predicted molecules will be synthesized and delivered to Pfizer.
cgenUnusual 11 Mid-Day Movers 12/23: CGEN, PSDV, NCT, FSII, DRAM Hig...StreetInsider.com News Articles Wed, 12/23/2009 - 12:23
|
